Skip to content
Open access

From cardiovascular-kidney-metabolic syndrome to cardio-renal-hepatic-metabolic syndrome: a framework destined to expand further?

Sep 2026 · Giornale di Clinica Nefrologica e Dialisi · 0 citations · 4 references

Abstract

Cardiovascular-kidney-metabolic syndrome (CKM) represents an integrated clinical model describing the interaction among different organs and systems. Recent evidence suggests an expansion of this paradigm, including the liver as a relevant organ involved in systemic inflammatory and metabolic processes.Metabolic dysfunction-associated steatotic liver disease (MAFLD) is increasingly recognized as a component of the metabolic network, contributing to chronic inflammation and increased cardiovascular and renal risk. In this context, an extended model, referred to as  cardio-renal-hepatic-metabolic syndrome (CRHM), has been proposed, reflecting a broader and more integrated view of this complex pathological condition.This framework currently represents an evolving pathophysiological hypothesis requiring further clinical validation.A future expansion of the multiorgan pathological network cannot be excluded, considering the shared pathophysiological mechanisms and their pleiotropic effects. An integrated approach may improve risk stratification and guide more personalized therapeutic strategies.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.